AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC – Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 44,500 shares, a growth of 18.7% from the April 15th total of 37,500 shares. Based on an average daily trading volume, of 19,200 shares, the […]
Akumin (NASDAQ:AKU – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Analyst Ratings This is a summary of recent recommendations […]
Biodesix (NASDAQ:BDSX – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation. Earnings & Valuation This table compares Biodesix and AnPac […]
Biodesix (NASDAQ:BDSX – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Insider & Institutional Ownership 45.8% of AnPac Bio-Medical Science […]
AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 28,000 shares, a drop of 7.6% from the March 15th total of 30,300 shares. Based on an average trading volume of 27,300 shares, the days-to-cover ratio is currently […]